Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06588673 · ClinicalTrials.gov registry record · NA
Art Therapy in Progressive Supranuclear Palsy
A NA study of Progressive Supranuclear Palsy, sponsored by Vanderbilt University Medical Center.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06588673 is a NA study of Progressive Supranuclear Palsy that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 10 participants, below the 451-participant average among 18 other Progressive Supranuclear Palsy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06588673, a NA study of Progressive Supranuclear Palsy, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Our aim is to study the effect of art therapy for people with PSP, with a focus on alleviating the symptoms associated with PSP, enhancing the overall quality of life for patients, and reducing caregiver stress. Overall, through our collaborative efforts on this study, we hope to unlock the benefits of art therapy for this vulnerable patient population, ultimately improving their overall well-being and enhancing their quality of life.
Conditions Studied
Interventions
- OTHER Art Thrapy
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-01-14 |
| Est. Completion | 2026-12-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06588673
The ClinicalTrials.gov registry entry for NCT06588673 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 451-participant average among 18 other Progressive Supranuclear Palsy trials with a reported enrollment target (98% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Progressive Supranuclear Palsy appearing as the primary indexed condition, and to 1 intervention - of which Art Thrapy is the first listed.
NCT06588673 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT06588673 about?
NCT06588673 is a clinical study titled "Art Therapy in Progressive Supranuclear Palsy". Our aim is to study the effect of art therapy for people with PSP, with a focus on alleviating the symptoms associated with PSP, enhancing the overall quality of life for patients, and reducing caregiver stress. Overall, through our collaborative efforts on this study, we hope to unlock the benefits...
What is the current status of trial NCT06588673?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-01-14. Estimated completion is 2026-12-02.
What conditions does trial NCT06588673 study?
This clinical trial studies the following conditions: Progressive Supranuclear Palsy.
What interventions are being tested in trial NCT06588673?
The interventions under investigation include: Art Thrapy (OTHER).
Who is sponsoring clinical trial NCT06588673?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06588673 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Progressive Supranuclear Palsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
RECRUITING · NA
-
Community Outreach for Palliative Engagement -- Parkinson Disease
ACTIVE NOT RECRUITING · NA
-
Cholinergic Mechanisms of Attentional-motor Integration and Gait Dysfunction in Parkinson Disease (UDALL)
ACTIVE NOT RECRUITING · NA
-
Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
COMPLETED · NA
-
In-Home Care for Patients With PSP and Related Disorders
COMPLETED · NA
-
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.